Paclitaxel and Carboplatin Combination as 1st Line Treatment in Ovarian Carcinomas

NCT00750386 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Paclitaxel
DRUG: Carboplatin

Sponsor

Hellenic Oncology Research Group

Collaborators

[object Object]